January 1, 2024 - December 31, 2024
- Consolidated Financial Summary (IFRS) Fiscal 2024 Second Quarter (667KB)
- Appendix to the Consolidated Financial Summary (IFRS) Fiscal 2024 Second Quarter (995KB)
- Results Presentation Fiscal 2024 Second Quarter (1,803KB)
- Transcript of Results Briefing Fiscal 2024 Second Quarter (2,175KB)
- Revenues from other products (12KB)
January 1, 2023 - December 31, 2023
- Consolidated Financial Summary (IFRS) Fiscal 2023 (846KB)
- Appendix to the Consolidated Financial Summary (IFRS) Fiscal 2023 (1,189KB)
- Results Presentation Fiscal 2023 (2,173KB)
- Transcript of Results Briefing Fiscal 2023 (3,858KB)
- Revenues from other products (12KB)
- Annual Securities Report (1,909KB)
- Consolidated Financial Summary (IFRS) Fiscal 2023 Third Quarter (674KB)
- Appendix to the Consolidated Financial Summary (IFRS) Fiscal 2023 Third Quarter (1,125KB)
- (Correction) Appendix to the Consolidated Financial Summary Fiscal 2023 Third Quarter (304KB)
- Results Presentation Fiscal 2023 Third Quarter (1,071KB)
- Transcript of Results Presentation Fiscal 2023 Third Quarter (text) (2,293KB)
- Consolidated Financial Summary (IFRS) Fiscal 2023 Second Quarter (702KB)
- Appendix to the Consolidated Financial Summary (IFRS) Fiscal 2023 Second Quarter (930KB)
- (Correction) Appendix to the Consolidated Financial Summary Fiscal 2023 Second Quarter (130KB)
- Results Presentation Fiscal 2023 Second Quarter (1,183KB)
- Transcript of Results Briefing Fiscal 2023 Second Quarter (2,085KB)
- Revenues from other products (28KB)
January 1, 2022 - December 31, 2022
- Consolidated Financial Summary (IFRS) Fiscal 2022 (818KB)
- Appendix to the Consolidated Financial Summary Fiscal 2022 (1,443KB)
- Results Presentation Fiscal 2022 (1,118KB)
- Transcript of Results Briefing Fiscal 2022 (2,974KB)
- Revenues from other products (27KB)
- Annual Securities Report (1,814KB)
January 1, 2021 - December 31, 2021
- Consolidated Financial Summary Fiscal 2021 Second Quarter (720KB)
- Appendix to the Consolidated Financial Summary Fiscal 2021 Second Quarter (889KB)
- Results Presentation Fiscal 2021 Second Quarter (566KB)
- Revenues from other products (25KB)
- Transcript of Results Briefing Fiscal 2021 Second Quarter (text) (1,500KB)
January 1, 2020 - December 31, 2020
- Consolidated Financial Summary Fiscal 2020 (601KB)
- Appendix to the Consolidated Financial Summary Fiscal 2020 (345KB)
- Results Presentation Fiscal 2020 (448KB)
- Summary of late-stage clinical trials (566KB)
- Revenues from other products (25KB)
- Transcript of FY 2020 Results/2021-2025 Medium Term Business Plan Briefing (text) (2,712KB)
- Consolidated Financial Summary Fiscal 2020 Interim (2,121KB)
- Appendix to the Consolidated Financial Summary Fiscal 2020 Interim (573KB)
- Results Presentation Fiscal 2020 Interim (735KB)
- Summary of clinical trials (627KB)
- Revenues from other products (22KB)
- Transcript of Results Presentation Fiscal 2020 Interim (text) (1,274KB)
January 1, 2019 - December 31, 2019
- Consolidated Financial Summary Fiscal 2019 (452KB)
- Appendix to the Consolidated Financial Summary Fiscal 2019 (765KB)
- Results Presentation Fiscal 2019 (1,045KB)
- Summary of late-stage clinical trials (187KB)
- Revenues from other products (23KB)
- Transcript of Results Presentation Fiscal 2019 (text) (1,499KB)
- Consolidated Financial Summary Fiscal 2019 Interim (251KB)
- Appendix to the Consolidated Financial Summary Fiscal 2019 Interim (490KB)
- Results Presentation Fiscal 2019 Interim (740KB)
- Summary of late-stage clinical trials (227KB)
- Revenues from other products (23KB)
- Transcript of Results Presentation Fiscal 2019 Interim (text) (1,035KB)